Topical photodynamic therapy for patients with therapy-resistant lesions of cutaneous T-cell lymphoma

Journal of the American Academy of Dermatology

Volumn 50, Issue 3, 2004, Pages 363-367

  Coors, Esther A ^a,b   Von Den Driesch, Peter ^b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF HAMBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID;

ADULT; ARTICLE; CANCER REGRESSION; CASE REPORT; CUTANEOUS T CELL LYMPHOMA; HUMAN; MALE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 1542344334     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(03)00868-5     Document Type: Article

References (17)

1. Holloway KB, Flowers FP, Ramos Caro FA. Therapeutic alternatives in cutaneous T-cell lymphoma. J Am Acad Dermatol 1992;27:367-78.
2. Muche JM, Gellrich S, Sterry W. Treatment of cutaneous T-cell lymphomas. Semin Cutan Med Surg 2000;19:142-8.
3. Wolf P. Photodynamic therapy (PDT). Hautarzt 1997;48:137-48.
4. Wang I, Bendsoe N, Klinteberg CA, Enejder AM, Andersson-Engels S, Svanberg S, et al. Photodynamic therapy vs cryosurgery of basal cell carcinomas: results of a phase III clinical trial. Br J Dermatol 2001;144:832-40.
5. Boehncke WH, Kaufmann R. Photodynamic therapy at the threshold of clinical use in disseminated dermatoses. Hautarzt 1996;47:825-31.
6. Boehncke WH, Konig K, Ruck A, Kaufmann R, Sterry W. In vitro and in vivo effects of photodynamic therapy in cutaneous T-cell lymphoma. Acta Derm Venereol 1994;74:201-5.
7. Hunt DW, Jiang H, Granville DJ, Chan AH, Leong S, Levy JG. Consequences of the photodynamic treatment of resting and activated peripheral T lymphocytes. Immunopharmacology 1999;41:31-44.
8. Fox FE, Niu Z, Tobia A, Rook AH. Photoactivated hypericin is an anti-proliferative agent that induces a high rate of apoptotic death of normal, transformed, and malignant T lymphocytes: Implications for the treatment of cutaneous lymphoproliferative and inflammatory disorders. J Invest Dermatol 1998;111:327-32.
9. Kennedy JC, Pottier RH, Pross DC. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol B 1990;6:143-8.
10. Shanler SD, Buscaglia DA, van Leengoed H, Wan W, Whitaker JE, Mang TS, et al. PDT with topical d-Aminolevulinic acid for treatment of patch and plaque stage cutaneous T-cell lymphoma. J Invest Dermatol 1994;102:615.
11. Babich D, Whitaker JE, Conti C, Blaird-Wagner D, Stoll HL, Dozier S, et al. Treatment of all stages of cutaneous T-cell lymphomas with fractionated photodynamic therapy using topical d-Aminolevulinic acid (ALA-PDT). J Invest Dermatol 1996;106:840.
12. Svanberg K, Andersson T, Killander D, Wang I, Stenram U, Andersson-Engels S, et al. Photodynamic therapy of non-melanoma malignant tumours of the skin using topical delta-amino levulinic acid sensitization and laser irradiation. Br J Dermatol 1994;130:743-51.
13. Orenstein A, Haik J, Tamir J, Winkler E, Trau H, Malik Z, et al. Photodynamic therapy of cutaneous lymphoma using 5-aminolevulinic acid topical application. Dermatol Surg 2000;26:765-9.
14. Wolf P, Fink Puches R, Cerroni L, Keri H. Photodynamic therapy for mycosis fungoides after topical photosensitization with 5-aminolevulinic acid. J Am Acad Dermatol 1994;31:678-80.
15. Eich D, Eich HT, Otte HG, Ghilescu V, Stadler R. Photodynamic therapy of cutaneous T-cell lymphoma at special sites. Hautarzt 1999;50:109-14.
16. Wang I, Bauer B, Andersson-Engels S, Svanberg S, Svanberg K. Photodynamic therapy utilising topical delta-aminolevulinic acid in non-melanoma skin malignancies of the eyelid and the periocular skin. Acta Ophthalmol Scand 1999;77:182-8.
17. Ammann R, Hunziker T. Photodynamic therapy for mycosis fungoides after topical photosensitization with 5-aminolevulinic acid. J Am Acad Dermatol 1995;33:541.